These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6039632)

  • 1. The effect of adrenal function of treatment of eczema and psoriasis with triamcinolone acetonide.
    Keczkes K; Frain-Bell W; Honeyman AL; Sprunt G
    Br J Dermatol; 1967; 79(8):475-86. PubMed ID: 6039632
    [No Abstract]   [Full Text] [Related]  

  • 2. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion.
    Taylor KS; Malkinson FD; Gak C
    Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies with Halcinonide and fluocortolone in local administration].
    Reinhard W; Weber G; Petres J
    Z Hautkr; 1974 Apr; 49(7):267-72. PubMed ID: 4275779
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of topically applied beclamethasone dipropionate on adrenal function.
    Raffle EJ; Frain-Bell W
    Br J Dermatol; 1967; 79(8):487-90. PubMed ID: 6039633
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experiences with hydrocortisone 17-butyrate.
    Yasuda T
    Dermatologica; 1976; 152 Suppl 1():221-9. PubMed ID: 782956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal suppression with topical hydrocortisone butyrate.
    Hendrikse JC; Moolenaar AJ
    Dermatologica; 1973; 147(3):191-7. PubMed ID: 4780208
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the systemic effect of extensively applied topical steroids].
    Holzmann H; Morsches B; Gebhardt R
    Arztl Forsch; 1972 May; 26(5):171-7. PubMed ID: 5068154
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of localized skin lesions with betamethasone 17-valerate and triamcinolone acetonide in alcoholic solution under occlusive dressing. A double blind comparative study.
    Neering H; van der Kroon HV; Roeleveld CG
    Dermatologica; 1972; 145(6):395-9. PubMed ID: 4571883
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Besnier's prurigo with Calmuril-hydrocortisone 1% cream and triamcinolone acetonide 0,1% cream. A controlled clinical study].
    Ludvigsen KE; Gadborg E
    Ugeskr Laeger; 1975 May; 137(19):1062-4. PubMed ID: 1094657
    [No Abstract]   [Full Text] [Related]  

  • 10. Triamcinolone acetonide in flexible collodion for dermatologic therapy.
    Brock W; Cullen SI
    Arch Dermatol; 1967 Aug; 96(2):193-4. PubMed ID: 5341841
    [No Abstract]   [Full Text] [Related]  

  • 11. Pituitary-adrenal function after prolonged use of topical corticosteroids.
    Munro DD; Clift DC
    Br J Dermatol; 1973 Apr; 88(4):381-5. PubMed ID: 4712220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of eczema].
    Harnack K
    Z Arztl Fortbild (Jena); 1974 Jun; 68(11):534-8. PubMed ID: 4439985
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative clinical trials of three topical preparations in various forms of eczema].
    Weitgasser N
    Hautarzt; 1973 Dec; 24(12):555-8. PubMed ID: 4599163
    [No Abstract]   [Full Text] [Related]  

  • 14. Tibicorten and betamethasone valerate: a double-blind comparative study.
    Tazelaar DJ
    J Int Med Res; 1977; 5(5):338-45. PubMed ID: 334605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrophic skin striae following local corticosteroid therapy].
    Gschwandtner WR
    Hautarzt; 1973 Feb; 24(2):70-3. PubMed ID: 4691631
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new steroid for the treatment of psoriasis and eczema].
    Fredriksson T
    Lakartidningen; 1973 Aug; 29(35):2967-8. PubMed ID: 4790430
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic results of cortobenzolone (Tuplix) ointment used in various dermatoses (psoriasis and eczema)].
    Martínez-Fresneda CG
    Actas Dermosifiliogr; 1976; 67(11-12):757-66. PubMed ID: 80933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Means of increasing the therapeutic efficacy of corticosteroid ointments].
    Shekrota GS
    Vestn Dermatol Venerol; 1968 Mar; 42(3):65-6. PubMed ID: 5741249
    [No Abstract]   [Full Text] [Related]  

  • 19. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.
    Medansky RS; Bressinck R; Cole GW; Deeken JH; Ellis CN; Guin JD; Herndon JH; Lasser AE; Leibsohn E; Menter MA
    Cutis; 1988 Nov; 42(5):480-5. PubMed ID: 3058398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potency of percutaneously absorbed corticosteroids in the suppression of pituitary-adrenal function.
    Scoggins RB; Kliman B
    J Invest Dermatol; 1965 Nov; 45(5):347-55. PubMed ID: 5321337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.